Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial
Stephen Pianko, MD, PhD; Steven L. Flamm, MD; Mitchell L. Shiffman, MD; Sonal Kumar, MD; Simone I. Strasser, MD; Gregory J. Dore, MD; John McNally, PhD; Diana M. Brainard, MD; Lingling Han, PhD; Brian Doehle, PhD; Erik Mogalian, PhD; John G. McHutchison, MD; Mordechai Rabinovitz, MD; William J. Towner, MD; Edward J. Gane, MD; Catherine A.M. Stedman, MD; K. Rajender Reddy, MD; and Stuart K. Roberts, MD

Leave a Reply

Your email address will not be published. Required fields are marked *